 EDEN PRAIRIE, Minn., Sept. 23, 2021 PRNewswire -- NeuroOne Medical Technologies Corporation Nasdaq: NMTC NeuroOne or the Company, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it successfully completed an animal feasibility study of its combination recording and ablation technology at T3 Labs and Georgia StateGeorgia Tech Center for Advanced Brain Imaging in Atlanta Georgia under the guidance of Dr. Robert Gross of Emory University. 